<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000482.v1.p1" parentStudy="phs000482.v1.p1" createDate="2012-03-22" modDate="2012-08-28">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Evan E. Eichler, PhD</td><td>Department of Genome Sciences, University of Washington School of Medicine, Seattle, Washington, USA; Howard Hughes Medical Institute, Seattle, WA, USA</td></tr>
		<tr><td>Co-Principal Investigator</td><td>Jay Shendure, MD, PhD</td><td>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</td></tr>
		<tr><td>Other Investigators</td><td>Brian J. O&#39;Roak, PhD</td><td>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</td></tr>
		<tr><td>Other Investigators</td><td>Laura Vives, MS</td><td>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</td></tr>
		<tr><td>Other Investigators</td><td>Santhosh Girirajan, PhD</td><td>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Sporadic Autism Exomes Reveal a Highly Interconnected Protein Network of De Novo Mutations</StudyNameEntrez>
	<StudyNameReportPage>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Parent-Offspring Trios</StudyType>
		<StudyType>Parent-Offspring Quads</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>It is well established that autism spectrum disorders (ASD) have a strong genetic component; however, for at least 70% of cases, the underlying genetic cause is unknown. Under the hypothesis that de novo mutations underlie a substantial fraction of the risk for developing ASD in families with no previous history of ASD or related phenotypes-so-called sporadic or simplex families-we sequenced all coding regions of the genome (the exome) for parent-child trios exhibiting sporadic ASD, including 189 new trios and 20 that were previously reported. Additionally, we also sequenced the exomes of 50 unaffected siblings corresponding to these new (n = 31) and previously reported trios (n = 19), for a total of 617 individual exomes from 209 families deposited in dbGaP. Here we show that de novo point mutations are overwhelmingly paternal in origin (4:1 bias) and positively correlated with paternal age, consistent with the modest increased risk for children of older fathers to develop ASD. Moreover, 39% (49 of 126) of the most severe or disruptive de novo mutations map to a highly interconnected beta-catenin/chromatin remodelling protein network ranked significantly for autism candidate genes. In proband exomes, recurrent protein-altering mutations were observed in two genes: CHD8 and NTNG1. Mutation screening of six candidate genes in 1,703 ASD probands identified additional de novo, protein-altering mutations in GRIN2B, LAMC3 and SCN1A. Combined with copy number variant (CNV) data, these results indicate extreme locus heterogeneity but also provide a target for future discovery, diagnostics and therapeutics.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Trios (Father, Mother, and Proband) (n=189) <ul> <li>Exclusions:</li> <ul> <li>Known large CNVs as identified in Sanders et al., 2011. [PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/21658581" target="_blank">21658581</a>]</li> </ul> <li>Included:</li> <ul> <li>86 males affected with ASD but not intellectual disability</li> <li>47 males affected with ASD and intellectual disability</li> <li>30 females affected with ASD but not intellectual disability</li> <li>26 females with ASD and intellectual disability</li> </ul> </ul> </p> <p>Unaffected Siblings (n=50) <ul> <li>Exclusions:</li> <ul> <li>None</li> </ul> <li>Included:</li> <ul> <li>19 siblings matching probands from O&#39;Roak et al., 2011. [PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/21572417" target="_blank">21572417</a>]</li> <li>31 siblings matching the probands listed above.</li> </ul> </ul> </p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="21572417"/>
		</Publication>
		<Publication>
			<Journal authors="Brian J. O&#39;Roak, Laura Vives, Santhosh Girirajan, Emre Karakoc, Nik Krumm, Bradley P. Coe, Roie Levy, Arthur Ko, Choli Lee, Joshua D. Smith, Emily H. Turner, Ian B. Stanaway, Benjamin Vernot, Maika Malig, Carl Baker, Beau Reilly, Joshua M. Akey, Elhanan Borenstein, Mark J. Rieder, Deborah A. Nickerson, Raphael Bernier, Jay Shendure and Evan E. Eichler" title="Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations" journal="Nature. 2012. In Press"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Autistic Disorder"/>
		<Disease vocab_source="MESH" vocab_term="Child Development Disorders, Pervasive"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Evan E. Eichler, PhD</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, Washington, USA; Howard Hughes Medical Institute, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Co-Principal Investigator">
			<AttName>Jay Shendure, MD, PhD</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Brian J. O&#39;Roak, PhD</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Laura Vives, MS</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Santhosh Girirajan, PhD</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Emre Karakoc, PhD</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Nik Krumm, BS</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Bradley P. Coe, PhD</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Roie Levy, BS</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Arthur Ko, BS</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Choli Lee, BS</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Joshua D. Smith, MS</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Emily H. Turner, PhD</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Ian B. Stanaway, BS</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Benjamin Vernot, BS</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Maika Malig, BS</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Carl Baker, BS</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Beau Reilly, PhD</AttName>
			<Institution>Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Joshua M. Akey, PhD</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Elhanan Borenstein, PhD</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA; Department of Computer Science and Engineering, University of Washington, Seattle, WA, USA; Santa Fe Institute, Santa Fe, NM, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Mark J. Rieder, PhD</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Deborah A. Nickerson, PhD</AttName>
			<Institution>Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Other Investigators">
			<AttName>Raphael Bernier, PhD</AttName>
			<Institution>Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>SFARI 137578</AttName>
			<Institution>Simons Foundation, New York, NY, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>SFARI 191889</AttName>
			<Institution>Simons Foundation, New York, NY, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>HD065285</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>Research Fellow (EB)</AttName>
			<Institution>Alfred P. Sloan Foundation, New York, NY, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>Investigator (EEE)</AttName>
			<Institution>Howard Hughes Medical Institute, Seattle, WA, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="AARD" longName="Autism and Autism Related Disorders"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIMH</DacName>
      <DacFullName>NIMH</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000482.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000482.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000482.v1.p1" FileName="DUC_for_Eichler_phs482_v042110-1.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Autism and Autism Related Disorders</ConsentName>
        <ConsentAbbrev>AARD</ConsentAbbrev>
        <UseLimitation>for use in research on autism and autism related disorder.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
